Ultralife Corporation was founded in Delaware in December 1990. The company designs and manufactures power and communication systems, including batteries, charging systems and electronics, serving government, defense and commercial sectors around the world. It operates through two divisions, battery and energy products and communication systems, and has launched a rebranding plan to integrate its sub-brands into a unified main brand. 

Ultralife (ULBI) shares rose 15.79% in intraday trading after reporting a second-quarter earnings beat. The company posted GAAP EPS of $0.15, up from $0.05 year-over-year, alongside gross margin expansion to 28.9%. Additionally, Ultralife reported a record backlog of $117.5 million, signaling strong future revenue visibility despite a slight 1.3% decline in top-line revenue.

Ultralife (ULBI) shares jump 15.79% intraday after Q2 earnings beat

Ultralife (ULBI) shares surged 17.15% in intraday trading on August 7 after the company reported first-quarter earnings per share of $0.15 and revenue of $47.9 million.

Ultralife (ULBI) Rises 17.15% After Q1 Earnings Beat

Ultralife (ULBI) shares rose 12.39% in premarket trading after the company reported second-quarter 2026 earnings results that beat prior-year performance, with GAAP EPS of $0.15 compared to $0.05. The company also highlighted a record backlog of $117.5 million and improved gross margins of 28.9%.

Ultralife (ULBI) shares rise 12.39% premarket after Q2 2026 earnings beat and record backlog

• Ultralife Corporation to report Q2 results on Aug 7, 2026
• Management to host investor conference call at 8:00 AM ET
• Pre-register for phone call using link: https://register-conf.media-server.com/register/BI4beea58f157a441ba44284b283b1001fUltralife Corporation (NASDAQ: ULBI) is scheduled to <a href="https://investor.ultralifecorporation.com/news-releases/news-release-details/ultralife-corporation-report-second-quarter-results-august-7">report its second quarter 2026</a> financial results on Thursday, August 7, 2026, before the market opens. The company will also <a href="https://investor.ultralifecorporation.com/news-releases/news-release-details/ultralife-corporation-report-second-quarter-results-august-7">host an investor conference call</a> and simultaneous webcast at 8:00 AM ET on the same day to discuss the results. Participants planning to join the call by phone are required to <a href="https://register-conf.media-server.com/register/BI4beea58f157a441ba44284b283b1001f">pre-register using the link</a>: https://register-conf.media-server.com/register/BI4beea58f157a441ba44284b283b1001f. This will ensure a seamless connection and eliminate the need to interact with an operator during the call.The live webcast will be accessible through the Events &amp; Presentations section of Ultralife’s investor relations website at <a href="https://investor.ultralifecorporation.com/news-releases/news-release-details/ultralife-corporation-report-second-quarter-results-august-7">http://investor.ultralifecorporation.com</a>. A replay of the webcast will be available shortly after the call concludes. Ultralife operates through two primary segments: Battery &amp; Energy Products and Communications Systems, <a href="https://www.marketbeat.com/earnings/reports/2026-7-27-ultralife-co-stock/">serving defense, medical, industrial markets</a> globally. Investors will be looking closely at the company’s performance in these segments, particularly in light of recent trends in demand and operational efficiency initiatives.

Ultralife

Ultralife to Report Q2 Results on Aug. 7, Host Investor Call

Ultralife Corporation has been initiated with an "Underperform" recommendation by Zacks Investment Research due to concerns over ongoing operational and profitability challenges. The company's first-quarter 2026 results showed declining revenues and sharply compressed margins due to manufacturing disruptions, shipment delays, higher operating costs, and production inefficiencies. Despite a record backlog and growth initiatives, manufacturing inefficiencies, acquisition-related debt, and exposure to government procurement cycles could weigh on its future performance.Ultralife Corporation has been assigned an "Underperform" recommendation by Zacks Investment Research, reflecting concerns about its operational and profitability challenges[1]. The company’s first-quarter 2026 results revealed declining revenues and significantly compressed margins, attributed to manufacturing disruptions, shipment delays, rising operating costs, and <a href="https://example.com">production inefficiencies</a>. Although Ultralife maintains a record backlog and is pursuing growth initiatives, analysts remain cautious about its ability to overcome <a href="https://example.com">ongoing manufacturing constraints</a> and manage acquisition-related debt. Additionally, the company’s performance is closely tied to government procurement cycles, which <a href="https://example.com">introduce uncertainty into its revenue</a> outlook. These factors collectively raise questions about Ultralife’s capacity to sustainably improve its financial performance in the near term. Investors are advised to monitor the company’s progress in addressing operational bottlenecks and its <a href="https://example.com">ability to execute strategic initiatives</a> effectively.

ULBI News